Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.34 USD | -0.27% | -6.03% | -12.42% |
10/05 | Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating | MT |
09/05 | Xenon Pharmaceuticals Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.42% | 3.05B | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- XENE Stock
- News Xenon Pharmaceuticals Inc.
- Wedbush Raises Xenon Pharmaceuticals' Price Target to $47 From $44, Keeps Outperform Rating